Increase/Decrease in Cash: The total change in cash for the company over the given period.
Sarepta Therapeutics, Inc. (SRPT) had Increase/Decrease in Cash of $-304.18M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.20B |
|
$-713.41M |
|
$839.61M |
|
$1.36B |
|
$2.90B |
|
$-699.78M |
|
$-2.44M |
|
$-702.23M |
|
$-702.23M |
|
$-713.41M |
|
$-713.41M |
|
$-713.41M |
|
$-713.41M |
|
$-699.78M |
|
$-660.55M |
|
100.12M |
|
100.12M |
|
$-7.13 |
|
$-7.13 |
|
| Balance Sheet Financials | |
$2.54B |
|
$345.12M |
|
$811.76M |
|
$3.35B |
|
$1.10B |
|
$828.97M |
|
$1.11B |
|
$2.21B |
|
$1.14B |
|
$1.14B |
|
$1.14B |
|
104.96M |
|
| Cash Flow Statement Financials | |
$-205.48M |
|
$69.64M |
|
$-168.34M |
|
$1.12B |
|
$814.41M |
|
|
Increase/Decrease in Cash |
$-304.18M |
$123.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.32 |
|
-- |
|
-- |
|
0.42 |
|
0.73 |
|
61.81% |
|
-31.83% |
|
-31.83% |
|
-30.05% |
|
-31.94% |
|
-32.45% |
|
$-307.45M |
|
-- |
|
-- |
|
-- |
|
0.66 |
|
0.92 |
|
5.52 |
|
66.12 |
|
-62.55% |
|
-62.55% |
|
-21.30% |
|
-36.22% |
|
$10.87 |
|
$-3.07 |
|
$-2.05 |
|